Skip to main content
    A

    Avita Medical Ltd (RCEL)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $15.65
    -1.06 (-6.34%)

    Market Cap: $484.00M

    Last updated: Oct 30, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(14/28)
    Avg Surprise
    -33.76%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.29
    Range$-0.36 - $-0.23
    4 analysts
    EPS Revisions
    1
    0
    7d
    4
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.35+17.2%
    60d ago$-0.29+0.5%
    30d ago$-0.29-0.5%
    7d ago$-0.29-0.5%
    Current$-0.29
    Revenue Consensus
    $32M
    Range$32M - $33M
    4 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.48
    Range$-0.28 - $2.54
    4 analysts
    Revenue Consensus
    $38M
    Range$37M - $40M
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.48---
    Sep 26EST
    		-$-0.29---
    Jun 26
    Reported Aug 6
    		$-0.25$-0.39+35.90%Beat+34.2%
    Mar 26
    Reported May 14
    		$-0.48$-0.38-26.32%Miss+42.2%
    Dec 25
    Reported Feb 12
    		$-0.54$-0.55+1.82%Beat+22.7%
    Sep 25
    Reported Nov 6
    		$-0.71$-0.45-57.78%Miss-14.5%
    Jun 25
    Reported Aug 7
    		$-0.38$-0.26-46.15%Miss+58.2%
    Mar 25
    Reported May 8
    		$-0.83$-0.51-62.75%Miss+24.5%
    Dec 24
    Reported Feb 13
    		$-0.70$-0.74+5.97%Beat-62.4%
    Sep 24
    Reported Nov 7
    		$-0.62$-0.44-40.91%Miss-17.0%
    Jun 24
    Reported Aug 8
    		$-0.91$-0.76-19.74%Miss-44.4%
    Mar 24
    Reported May 13
    		$-1.10$-0.73-50.68%Miss-100.0%
    Dec 23
    Reported Feb 22
    		$-0.43$-0.57+24.56%Beat-38.7%
    Sep 23
    Reported Nov 9
    		$-0.53$-0.68+22.06%Beat-60.6%
    Jun 23
    Reported Aug 10
    		$-0.63$-0.46-36.96%Miss-80.0%
    Mar 23
    Reported May 11
    		$-0.55$-0.36-52.78%Miss+0.0%
    Dec 22
    Reported Feb 23
    		$-0.31$-0.41+24.39%Beat+8.8%
    Sep 22
    Reported Nov 10
    		$-0.33$-0.51+35.29%Beat-37.5%
    Jun 22
    Reported Aug 11
    		$-0.35$-0.57+38.60%Beat-105.9%
    Mar 22
    Reported May 12
    		$-0.55$-0.52-5.77%Miss-61.8%
    Dec 21
    Reported Feb 28
    		$-0.34$-0.37+7.76%Beat+0.0%
    Sep 21
    Reported Nov 8
    		$-0.24$-0.38+36.84%Beat+63.6%
    Jun 21
    Reported Aug 26
    		$-0.17$-0.29+41.38%Beat+71.7%
    Mar 21
    Reported May 13
    		$-0.34$-0.50+32.00%Beat+52.1%
    Dec 20
    Reported Feb 11
    		$-0.34$-0.59+42.37%Beat-413.6%
    Sep 20
    Reported Nov 10
    		$-0.66$-0.49-34.69%Miss-
    Jun 20
    Reported Aug 27
    		$-0.60$-0.24-150.00%Miss-
    Mar 20
    Reported Apr 29
    		$-0.71$-0.09-688.89%Miss-
    Dec 19
    Reported Feb 18
    		$-0.07$-0.03-120.67%Miss-
    Sep 19
    Reported Oct 31
    		$0.00N/A+100.00%Beat-
    Jun 19
    Reported Aug 29
    		$0.00$0.00N/ABeat-
    Mar 19
    Reported May 21
    		$0.00$0.00N/ABeat-
    Dec 18
    Reported Feb 27
    		$0.00$0.00N/ABeat-
    Sep 18
    Reported Oct 30
    		$0.00$0.00N/ABeat-
    Jun 18
    Reported Aug 30
    		$0.00$0.00N/ABeat-
    Mar 18
    Reported Apr 29
    		$0.00$0.00N/ABeat-
    Dec 17
    Reported Jan 30
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-7.90EV/EBITDAN/A
    Price/FCF-19.00xFCF Yield-5.26%
    Profitability
    Profit Margin-57.00%Operating Margin-31.60%
    ROE-1746.00%ROIC-172.56%
    Financial Health
    Debt/Equity-1.78xInterest Coverage-6.97x
    Current Ratio0.41xQuick Ratio0.34x
    Trading Statistics
    Beta1.99Avg Volume422.11K
    52-Week High$16.9052-Week Low$3.22

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$15.33
    SMA 20$14.27
    SMA 50$12.21
    SMA 200$6.55
    EMA 10$15.38
    EMA 20$14.42
    EMA 50$12.27
    EMA 200$7.95

    MACD

    Line: 1.24Signal: 1.12Hist: 0.12

    ADX

    ADX: 50.5+DI: 29.9-DI: 18.0

    Aroon & PSAR

    Aroon Up96.0
    Aroon Down4.0
    PSAR$14.23

    Bollinger Bands

    Upper Band$16.94
    Lower Band$11.60
    %B Position3737%(Upper)
    Band Width0.76

    RSI (14-Day)

    Neutral
    66.2

    Momentum Oscillators

    Stoch %K87.1
    Stoch %D92.1
    Williams %R-29.8
    ROC (10d)20.0%
    Momentum2.61
    CCI (20d)93.6
    MFI (14d)68.0

    Volatility Measures

    ATR (14d)$0.86(5.5%)
    StdDev (20d)1.33
    Hist Vol57.9%(High)

    Volume Flow

    VWAP$15.83
    OBV24.5M
    AD Line15.5M
    CMF (20d)0.281

    Volume Metrics

    Avg Vol (20d)419.9K
    Vol Ratio1.4x
    VWMA (20d)$14.47

    Pivot Points

    R3$17.44
    R2$17.17
    R1$16.94
    Pivot Point$16.67
    S1$16.44
    S2$16.17
    S3$15.94

    Advanced Oscillators

    TSI48.07
    Ultimate Osc66.0
    KST314.39

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$21.70M$19.25M$17.62M$17.06M$18.42M$18.51M$18.41M$19.55M$15.20M$11.10M$14.20M$13.64M
    Cost of Revenue$3.94M$3.52M$3.31M$3.19M$3.47M$2.83M$2.28M$3.19M$2.11M$1.51M$1.80M$2.11M
    Gross Profit$17.77M$15.73M$14.31M$13.88M$14.95M$15.68M$16.13M$16.36M$13.08M$9.59M$12.40M$11.53M
    Operating Expenses$24.62M$24.53M$24.72M$23.03M$26.10M$27.51M$26.08M$30.16M$28.71M$26.80M$24.67M$20.84M
    R&D$5.08M$5.63M$5.69M$3.75M$5.12M$6.28M$4.85M$5.43M$4.89M$5.19M$6.76M$4.39M
    SG&A$5.97M$6.06M$7.09M$7.23M$6.67M$6.39M$7.12M$9.59M$7.52M$8.96M$7.75M$6.12M
    Operating Income$-6,855,000$-8,803,000$-10,406,000$-9,153,000$-11,148,000$-11,827,000$-9,957,000$-13,806,000$-15,624,000$-17,206,000$-12,273,000$-9,306,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$1.46M$1.42M$1.25M$1.27M$1.25M$1.23M$1.30M$1.36M$1.35M$1.36M$1.12M$10,000
    Income Before Tax$-7,630,000$-10,622,000$-11,637,000$-13,172,000$-9,916,000$-13,851,000$-11,570,000$-16,233,000$-15,360,000$-18,628,000$-7,053,000$-8,701,000
    Income Tax Expense$33,000$-11,000$-16,000$15,000$4,000$8,000$19,000$-28,000$33,000$30,000$12,000$11,000
    Net Income$-7,663,000$-10,611,000$-11,621,000$-13,187,000$-9,920,000$-13,859,000$-11,589,000$-16,205,000$-15,393,000$-18,658,000$-7,065,000$-8,712,000
    EBITDA$-5,605,000$-8,648,000$-9,770,000$-11,361,000$-8,177,000$-12,225,000$-10,057,000$-14,891,000$-14,284,000$-17,746,000$-6,245,000$-8,615,000
    EBIT$-6,167,000$-9,198,000$-10,386,000$-11,904,000$-8,664,000$-12,618,000$-10,271,000$-14,874,000$-14,013,000$-17,272,000$-5,931,000$-8,691,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RCEL

    News

    Avita Medical (RCEL) Projected to Release Earnings on Thursday

    Avita Medical (NASDAQ:RCEL) is anticipated to release its Q3 2026 earnings after market close on Thursday, November 5th. Analysts are forecasting a loss of $0.2394 per share on revenues of $22.35 million. The company has...

    MarketBeat•10/29/26•Somewhat-Bullish

    AVITA Medical, Inc. (RCEL) Seasonal returns chart

    The article presents a seasonal returns chart for AVITA Medical, Inc. (RCEL), showing the average monthly price return from 2016 to 2026. It highlights the stock's performance with its current price and daily change...

    Yahoo Finance UK•10/28/26•Neutral

    Avita Medical, Inc. Estimates – NASDAQ:RCEL

    This page on TradingView provides financial actuals and analyst estimates for Avita Medical, Inc. (NASDAQ: RCEL). It allows users to explore reported financial data and compare actual results with average, high...

    TradingView•10/23/26•Neutral

    AVITA Medical (ASX:AVH) Is Up 246.03%: Is It Still Worth a Closer Look?

    AVITA Medical (ASX:AVH) shares have increased by 246.03% recently, with a 9.27% gain on October 22, 2026, closing at $4.36. The company reported record Q2 2026 net revenue of $21.7 million, an 18% year-on-year increase...

    Kalkine•10/22/26•Bullish

    AVITA Medical (ASX:AVH) Is Up 246.03%: Is It Still Worth a Closer Look?

    AVITA Medical (ASX:AVH) shares have seen a significant gain of 246.03%, with a 9.27% increase on October 22, 2026. The company reported record Q2 net revenue of $21.7 million, an 18% year-on-year increase...

    Kalkine•10/22/26•Bullish

    RCEL Valuation and Fair Value

    P/E
    -7.9x
    Forward P/E
    10.3x
    P/FCF
    -19.0x
    P/B
    -17.3x
    See GNG's fair value

    RCEL Profitability: Margins, ROIC and FCF

    Gross margin
    81.6%
    Operating margin
    -31.6%
    Net margin
    -57.0%
    ROIC
    -172.6%
    ROE
    -1746.0%
    FCF yield
    -5.3%

    RCEL Competitors

    CompanyTicker
    Evolus IncEOLS
    Gyre Therapeutics Inc.GYRE
    Delcath Systems IncDCTH
    Evolent Health IncEVH
    DiaMedica Therapeutics IncDMAC
    XOMA CorpXOMA
    CytomX Therapeutics IncCTMX
    Regenxbio IncRGNX

    Sector: Healthcare

    RCEL Analyst Ratings

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    0
    Buy
    3
    Hold
    0
    Sell
    0
    Strong Sell
    0

    RCEL Bull Case vs Bear Case

    Bull case

    • RCEL grew quarterly revenue 17.8% year over year.

    Bear case

    • RCEL has a -57.0% net profit margin.
    • RCEL beat EPS estimates in 37.5% of its last 8 reported quarters.

    RCEL Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -23.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.29
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    4 up, 0 down

    Frequently Asked Questions About RCEL

    Does RCEL pay dividends?

    Avita Medical Ltd (RCEL) does not currently pay a regular dividend.

    What is RCEL's market cap?

    Avita Medical Ltd (RCEL) has a market capitalization of $484.00M with a current stock price of $15.65.

    Related stocks

    Sector: Healthcare

    All stocks starting with R

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In